/Companies

IsoBio

Gladwyne, US · Founded 2025 · Delaware corporation

Find your way into IsoBio

Sign up to see every warm intro you have to IsoBio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the IsoBio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

BB
Bruce B. TurnerNamed on SEC filing

Board

TW
Todd WiderMr. Wider is the Director of the Issuer.
PM
Paul MannBoard director

Reported raises · per SEC filings

Form D private placements

$1.7M disclosed across 1 round · 2025

▶$1.7MraisedNov 2025 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd WiderDirector, Executive Officer, Promoter
  • Paul MannDirector
  • Bruce B. TurnerDirector, Executive Officer, Promoter
Offering amount
$3M
Amount sold
$1.7M
First sale
Oct 2025
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has IsoBio raised?
IsoBio has disclosed $1.7M raised across 1 round.
Where is IsoBio headquartered?
IsoBio is headquartered in Gladwyne, US.